Bull Harbor Capital LLC Invests $530,000 in The Cooper Companies, Inc. $COO

Bull Harbor Capital LLC acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 7,417 shares of the medical device company’s stock, valued at approximately $530,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Root Financial Partners LLC boosted its stake in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares in the last quarter. SJS Investment Consulting Inc. increased its position in shares of Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after purchasing an additional 187 shares in the last quarter. Cromwell Holdings LLC increased its position in shares of Cooper Companies by 128.8% during the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after purchasing an additional 273 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new stake in shares of Cooper Companies during the 2nd quarter valued at $36,000. Finally, Physician Wealth Advisors Inc. lifted its holdings in shares of Cooper Companies by 4,276.9% during the 4th quarter. Physician Wealth Advisors Inc. now owns 569 shares of the medical device company’s stock valued at $47,000 after purchasing an additional 556 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 0.5%

Shares of COO stock opened at $72.32 on Friday. The stock’s 50-day simple moving average is $68.36 and its 200-day simple moving average is $71.79. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The firm has a market capitalization of $14.10 billion, a PE ratio of 61.29, a P/E/G ratio of 1.90 and a beta of 0.84. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same period last year, the business posted $0.96 earnings per share. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Wall Street Analysts Forecast Growth

COO has been the topic of several research analyst reports. Piper Sandler set a $86.00 target price on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Stifel Nicolaus lowered their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a report on Friday, June 5th. Wells Fargo & Company restated a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. Finally, Needham & Company LLC cut their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $81.36.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.